Posted by AGORACOM-JC
at 8:10 AM on Tuesday, February 23rd, 2021
American Creek owns 20% of Treaty Creek, a project that is currently waiting on a maiden resource and estimated to be around 30 million ounces. It’s safe to assume if your flagship asset is within the scale of a world class asset such as Treaty Creek, your supporting assets are not being recognized for their value. This is where Stinger (STNG: TSXV) comes in. All non-core AMK assets are now the property of Stinger, including millions in cash and over 1m Tudor Gold shares. American Creek keeps the 20% carried Interest to production at Treaty Creek, and any future discoveries. Oh, and the very first Resource at Treaty Creek
2 Companies. 1 Bull Market. Sit back and have a listen to this great interview with Kelvin Burton as he explains for all shareholders, AMK and soon to be STNG.
Posted by AGORACOM-JC
at 10:52 AM on Monday, February 22nd, 2021
Announced today that Mr. P. Peter Pascali, CEO and Chair of PyroGenesis, has been invited to present at the prestigious 7 th Annual Gabelli & Company Waste Services Symposium being held virtually on Thursday, March 18th. Mr. Pascali will be presenting at 1:45pm ET.
MONTREAL, Feb. 22, 2021 — PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX: PYR) (OTCQB: PYRNF) (FRA: 8PY), (the “Company”, the “Corporation” or “PyroGenesis”) a Company that designs, develops, manufactures and commercializes plasma atomized metal powder, plasma waste-to-energy systems and plasma torch products, is pleased to announce today that Mr. P. Peter Pascali, CEO and Chair of PyroGenesis, has been invited to present at the prestigious 7 th Annual Gabelli & Company Waste Services Symposium being held virtually on Thursday, March 18th. Mr. Pascali will be presenting at 1:45pm ET.
“It is indeed an honor to be asked again to present at this distinguished conference,” said Mr. P. Peter Pascali, CEO & Chair of PyroGenesis. “I look forward to the event, and presenting to both existing and prospective investors, as well as to members of the environmental services industry.”
Posted by AGORACOM-JC
at 10:35 AM on Monday, February 22nd, 2021
Announces the results of the Special Meeting (the “Meeting”) held virtually on Friday February 19, 2021.
Authorization from the Company’s shareholders to enable the Board of Directors, within its sole discretion, to consolidate the Company’s issued and outstanding common shares on the basis of one post-consolidation common share for a number of pre-consolidation common shares ranging between two (2) and fourteen (14) as outlined in the Company’s management information circular and voting material sent to the shareholders.
TORONTO, Feb. 22, 2021 – POET Technologies Inc. (“ POET ” or the “ Company ”) (TSX Venture: PTK; OTCQX: POETF), the designer and developer of the POET Optical Interposer™ and Photonic Integrated Circuits (PICs) for the data center and tele-communication markets announces the results of the Special Meeting (the “Meeting”) held virtually on Friday February 19, 2021.
The Company’s Chairman and Chief Executive Officer, Dr. Suresh Venkatesan, conducted the formal business of the Meeting, which focused solely on seeking authorization from the Company’s shareholders to enable the Board of Directors, within its sole discretion, to consolidate the Company’s issued and outstanding common shares on the basis of one post-consolidation common share for a number of pre-consolidation common shares ranging between two (2) and fourteen (14) as outlined in the Company’s management information circular and voting material sent to the shareholders.
Posted by AGORACOM-JC
at 10:21 AM on Monday, February 22nd, 2021
Announce that it has established its previously announced scientific advisory board, (see press release dated January 20th, 2021) to assist the Company to accelerate existing applications and to develop new BioCloud technology applications.
“Now more than ever viral detection technology is critical to getting the economy and everyday life back to normal,” says Paul Ghezzi, CEO of Kontrol.
TORONTO, ON / February 22, 2021 /Kontrol Technologies Corp.(CSE:KNR)(OTCQB:KNRLF)(FSE:1K8) (“Kontrol Technologies” or “Kontrol” or “Company“) is pleased to announce that it has established its previously announced scientific advisory board, (see press release dated January 20th, 2021) to assist the Company to accelerate existing applications and to develop new BioCloud technology applications.
“Now more than ever viral detection technology is critical to getting the economy and everyday life back to normal,” says Paul Ghezzi, CEO of Kontrol. “Vaccines are integral to a broader recovery, however more technology is required for detection and monitoring. We are pleased to be taking a leadership role in this new industry of real-time viral detection infrastructure. Our technology was developed for the current pandemic and the pandemics of the future.”
“We are very pleased to establish a world class advisory board for Kontrol BioCloud,” says Gary Saunders, VP Kontrol. “Our advisory board members are at the top of their field and their counsel will be very important to the future of Kontrol BioCloud and other innovative applications of the technology we may seek to develop.”
Posted by AGORACOM-JC
at 9:53 AM on Monday, February 22nd, 2021
Else has developed a breakthrough, proprietary process to further ensure the safety of the formula.
This patent pending process will contribute greatly to Else’s realization of an infant formula in worldwide markets and provide higher standards of safety, health and natural nutrition for babies, toddlers and children.
VANCOUVER, BC , Feb. 22, 2021 – ELSE NUTRITION HOLDINGS INC. (TSXV: BABY) (OTCQX: BABYF) (FSE: 0YL) (“Else” or the “Company”) the plant-based baby, toddler and children nutrition company , announces as part of its progress towards commercializing a clean label, dairy-free and soy-free, plant-based infant formula, Else has developed a breakthrough, proprietary process to further ensure the safety of the formula. This patent pending process will contribute greatly to Else’s realization of an infant formula in worldwide markets and provide higher standards of safety, health and natural nutrition for babies, toddlers and children.
This new process builds on the company’s already clean and most natural production process that ensures the highest quality standards – it does not use harsh chemicals or detergents (commonly used in the industry) and does not impact the formula’s amino acids or other macronutrients.
“The World Health Organization considers the first 1000 days of life as critically important to long term health and wellness. It’s the window of time where optimum brain and immune system development is established. Infant formula is the exclusive form of nourishment for many babies during this critical period of development. The recent consumer and regulatory call to action is especially prudent to the formula category. Else Nutrition is voluntarily and proactively changing the way they source ingredients, manufacture their products, and think about food safety all in an effort to optimize environmental and public health now and into the future,” said Jaclyn Bowen MPH, MS food and consumer products safety and systems engineer and Executive Director of Clean Label Project.
“We’re leading a clean revolution, disrupting the baby food industry by setting a new standard in quality, transparency and sustainability. This latest development brings us even closer to bringing clean label, plant-based, minimally processed infant formula to wanting parents worldwide,” said Hamutal Yitzhak , CEO and Co-Founder of Else Nutrition.
The novel pre-process was under development for nearly a year. A full Pilot stage was successfully completed and tested recently at the company’s innovation center in Northern Israel , positively demonstrating reduction of specific elements levels.
Already a recipient of The Clean Label Project’s Purity Award (an honor only bestowed after products are tested for over 400 contaminants and heavy metals and meet the organization’s highest standard) for its Plant-Based Complete Nutrition for Toddlers product, Else continues its commitment to ‘cleaning up’ the baby/toddler nutrition aisles with safe, clean label products of the highest quality.
Else is proud to share this exciting development and its continued commitment to baby food safety and quality, in light of a recent congressional report that revealed that many baby food products offered by leading manufacturers contain significant levels of toxic heavy metals.
Else’s ‘Beyond Organic’ Processing
Else Nutrition is primarily made of almonds, tapioca and buckwheat; three core ingredients that go through a clean, all-natural process that provides the protein, carbohydrates, and fat directly from the whole plants, along with phytonutrients, fiber, vitamins and minerals nature intended to provide optimal nourishment for children. Else is free of dairy, soy and corn-syrup, and is made with non-GMO ingredients. It is made using a clean, most natural and sustainable industry process.
Posted by AGORACOM-JC
at 9:45 AM on Monday, February 22nd, 2021
Now eligible for electronic clearing and settlement through the Depository Trust Company (“DTC”) in the United States.
The Company’s common shares are traded on the OTCQB under the symbol “IDKFF”.
TORONTO, Feb. 22, 2021 — ThreeD Capital Inc. (the “Company” or “ThreeD”) (CSE:IDK) (OTCQB:IDKFF) is pleased to announce that the Company’s common shares are now eligible for electronic clearing and settlement through the Depository Trust Company (“DTC”) in the United States. The Company’s common shares are traded on the OTCQB under the symbol “IDKFF”.
DTC is a subsidiary of the Depository Trust and Clearing Corporation, a United States company that manages the electronic clearing and settlement of publicly traded companies. DTC services reduces costs and accelerates the settlement process for investors and brokers trading Canadian securities in the United States.
Sheldon Inwentash, CEO of ThreeD commented, “We are thrilled with obtaining DTC eligibility, as it represents an important step forward in increasing liquidity, broadening our shareholder base and building a strong presence for the Company within the US capital markets sphere.”
About ThreeD Capital Inc.
ThreeD is a publicly-traded Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors. ThreeD’s investment strategy is to invest in multiple private and public companies across a variety of sectors globally. ThreeD seeks to invest in early stage, promising companies where it may be the lead investor and can additionally provide investees with advisory services and access to the Company’s ecosystem.
For further information:
Jakson Inwentash Vice President Investments [email protected] Phone: 416-941-8900 ext 107
The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof.
Posted by AGORACOM-JC
at 8:00 PM on Sunday, February 21st, 2021
Earlier this month we told you about VSBLTY Groupe Technologies (VSBY:CSE) (VSBGF:US), a disruptive computer vision software company that is using A.I. and Machine Learning to transform the retail and security industries.
$VSBY Teaches Computers How to Interpret Surroundings. For example, detecting anomalies better than any human ever can
$VSBY Then Delivers the Context of Their Surroundings via Alerts, so that humans can make decisions and act on then faster than ever possible
$VSBY technology serves the dual function of both monitoring (i.e. a stadium, a store) and marketing (serving ads based on real-time demographics)
Since that first video, VSBLTY has issued three separate, major news releases:
On Feb 4, it partnered with 911inform on a deal to improve emergency response, safety & security in schools, hospitals & offices
On Feb 9, it unveiled a partnership with Ability Enterprise Co., which will see cutting-edge cameras integrated into a new media network of up to 10,000 convenience stores in Latin America.
On Feb 16, it penned a partnership with EOS Linx to provide a solar-powered security solution utilizing ai-driven proprietary software.
We sat down with Jay Hutton, VSBLTY’s co-founder, CEO and President, to break down the firm’s rapid expansion:
Tags: VSBY Posted in AGORACOM Via Satellite, VSBLTY Groupe Technologies Corp. | Comments Off on VIDEO – VSBLTY Groupe $VSBY.ca $VSBGF Is Ramping Up in the Digital Display Space, with Three Major Deals in the Past Two Weeks $MARK $AT
Posted by AGORACOM-JC
at 7:17 PM on Sunday, February 21st, 2021
ORTHO Regenerative Technologies is a cutting-edge med tech firm that uses its proprietary RESTORE technology platform to dramatically improve the success rate of orthopedic and sports medicine surgeries.
In layman’s terms, that means company has a wonder delivery platform that delivers biologics – drugs made from biological processes – to repair soft tissues in the human body.
The technology uses biologics derived from things like plasma and bone marrow concentrate to regenerate new tissue in various musculoskeletal conditions.
This includes Wound Healing, Cartilage repair and Osteo-arthritis
So, how big is the market opportunity for Soft Tissue Repair? At least $5bn in the U.S. alone. This includes:
Rotator Cuff TEAR (which leads to shoulder dysfunction and pain):
4m patients in the U.S. alone
600,000 annual surgeries in the U.S. alone
$600m+ market opportunity
Meniscus Tear Repair (which is painful and compromises knee function):
There are 1.2m surgeries annually in U.S. alone
$1bn+ market opportunity
Cartilage Lesions Repair (this is where lesions cause friction and pain):
1.2m detected lesions annually in U.S. alone
120,000 surgeries and a lack of options
$1bn+ market opportunity
Get comfy for this insightful interview with Claude LeDuc, Ortho’s CEO.
